ichorbio
ichorbio is a manufacturer of bulk in vivo antibodies and research biosimilars based in Oxford, United Kingdom.
At ichorbio, their vision is to develop the highest quality reagents to advance scientific research and progress. They believe that the excellence of our products directly impacts the meaningfulness of research outcomes.
As a boutique reagent manufacturer, their target customers are scientists seeking reliable antibodies and other research tools. They aim to provide these products at fair prices - keeping our focus on customers, not shareholders.
Thier best selling in vivo products include RMP1-14, 10F.9G2 and 2.43. Their best selling research biosimilars include mosunetuzumab, odronextamab and aflibercept. Their best selling isotype controls include Rat IgG2a isotype control, Rat IgG2b isotype control, Human IgG1 isotype control and Human IgG4 S228P isotype control.
Sekisui
BioProduction by Sekisui offers contract development and manufacturing services for the biopharmaceutical industry. Our facility in the UK has over 40 years of fermentation and purification experience with enzymes and proteins as our focus. We offer expertise in bioprocess development, scale up and manufacturing of enzymes, plasmids, antibody fragments and other proteins. We offer ISO 9001, ISO 13485 and GMP manufacturing quality standards for your custom production. We are in the process of a $19M expansion of our GMP facility for drug substance manufacturing which will complete in 2023.
Sphere Fluidics
Sphere Fluidics is developing picodroplets and single cell analysis systems and services for therapeutic discovery.
Specialities
Biopharmaceutical, lab-on-a-chip, cells, antibodies, microfluidics, enzymes, cancer, biologics, biotechnology, pharmaceutical, life sciences, immunology, oncology, cell therapies, and stem cells
